D. Babushok

发表

Current topics in genome evolution: Molecular mechanisms of new gene formation

E. Ostertag, H. Kazazian, D. Babushok, 2007, Cellular and Molecular Life Sciences.

Bone marrow failure syndromes

A. Hsu, D. Babushok, I. Dokal, 2020, Stiehm's Immune Deficiencies.

Germline POT1 Variants Can Predispose to Myeloid and Lymphoid Neoplasms

S. Carty, K. Nathanson, A. Bagg, 2021, Leukemia.

Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN‐associated portal hypertension

J. Mondschein, M. Streiff, J. Spivak, 2017, American journal of hematology.

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

T. Olson, Yash Shah, D. Babushok, 2021, Blood advances.

Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

D. Babushok, Lova Sun, 2020, Blood.

A brief, but comprehensive, guide to clonal evolution in aplastic anemia.

D. Babushok, 2018, Hematology. American Society of Hematology. Education Program.

Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

J. Biegel, D. Monos, T. Olson, 2017, Blood advances.

A novel testis ubiquitin-binding protein gene arose by exon shuffling in hominoids.

E. Ostertag, H. Kazazian, N. Okada, 2007, Genome research.

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Shannon R. McCurdy, M. Carroll, D. Porter, 2022, Blood advances.

Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.

J. Biegel, D. Monos, T. Olson, 2015, Cancer genetics.

Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia

D. Monos, D. Teachey, T. Olson, 2019, Pediatric Transplantation.

Diagnosis and Treatment of Aplastic Anemia

T. Olson, S. A. Peslak, D. Babushok, 2017, Current Treatment Options in Oncology.

Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes

H. Hakonarson, J. Biegel, T. Olson, 2013, British journal of haematology.

D. Babushok, Pamela J. Sung, 2020, Blood.

Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Leukemia & lymphoma.

Significance of RUNX1 mutation in BCR-ABL1 positive acute myeloid leukemia – a diagnostic dilemma in a young woman with persistent bleeding

M. Lim, D. Babushok, Sharmila Ghosh, 2022, Leukemia & lymphoma.

When does a PNH clone have clinical significance?

D. Babushok, 2021, Hematology. American Society of Hematology. Education Program.

Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32

T. Olson, D. Babushok, E. Hexner, 2018, Leukemia.

Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response

D. Babushok, E. Hexner, D. Frank, 2018, Leukemia & lymphoma.

Low dose total body irradiation added to fludarabine and busulfan reduced intensity conditioning reduces graft failure in patients with myelofibrosis.

D. Porter, A. Maity, J. Plastaras, 2022, Transplantation and cellular therapy.

Inherited bone marrow failure with macrothrombocytopenia due to germline tubulin beta class I (TUBB) variant

Meghan C Towne, Colin A. Ellis, T. Olson, 2022, British journal of haematology.

Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes.

T. Olson, E. L. Luning Prak, W. Meng, 2020, Blood advances.

Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.

D. Porter, D. Babushok, S. Luger, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.

Shannon R. McCurdy, D. Porter, D. Babushok, 2021, Transplantation and cellular therapy.

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia

Annette S. Kim, T. Libermann, L. Cohen, 2021, Blood advances.

Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype.

G. Wertheim, T. Olson, S. Meshinchi, 2018, Blood advances.

Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

D. Babushok, M. Bessler, 2015, Best practice & research. Clinical haematology.

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment and Length of Hospitalization in Myeloablative Allogeneic Hematopoietic Transplantation

Shannon R. McCurdy, D. Porter, D. Babushok, 2019, Biology of Blood and Marrow Transplantation.

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Shannon R. McCurdy, D. Porter, D. Babushok, 2018, Blood.

Progress in understanding the biology of the human mutagen LINE‐1

H. Kazazian, D. Babushok, 2007, Human mutation.

L1 integration in a transgenic mouse model.

E. Ostertag, H. Kazazian, D. Babushok, 2005, Genome research.

Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Leukemia & lymphoma.

JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

A. Bagg, D. Babushok, E. Hsi, 2018, British journal of haematology.

Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities

D. Monos, T. Olson, A. Bertuch, 2022, JCI insight.

Recent advances in understanding clonal haematopoiesis in aplastic anaemia

T. Olson, D. Babushok, Natasha L Stanley, 2017, British journal of haematology.

Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults

T. Olson, D. Babushok, M. Bessler, 2016, Leukemia & lymphoma.

Clonal hematopoiesis in patients with dyskeratosis congenita

J. Biegel, D. Babushok, N. Perdigones, 2016, American journal of hematology.

Disrupted lymphocyte homeostasis in hepatitis‐associated acquired aplastic anemia is associated with short telomeres

T. Olson, H. Xie, D. Babushok, 2016, American journal of hematology.

Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes.

K. Karczewski, T. Olson, M. Poncz, 2020, Blood advances.

Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract

D. Porter, D. Babushok, S. Luger, 2016 .

Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency

A. Bagg, D. Babushok, J. Juusola, 2020, Cold Spring Harbor molecular case studies.

Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation

T. Olson, Yash Shah, H. Xie, 2021, Blood advances.

Real World Survival Outcomes of CPX-351 Versus Venetoclax and Azacitadine for Initial Therapy in Adult Acute Myeloid Leukemia

Shannon R. McCurdy, D. Porter, K. Pratz, 2021, Blood.

Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.

A. Papazoglou, J. Biegel, D. Monos, 2014, Cancer genetics.

Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria

Sushant Kumar, D. Babushok, Bolormaa Munkhbileg, 2022, Frontiers in Immunology.

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

D. Porter, D. Babushok, S. Luger, 2019, Bone Marrow Transplantation.

Severe aplastic anaemia after serial vaccinations for SARS‐CoV‐2, pneumococcus and seasonal influenza

D. Babushok, D. Laczkó, G. Caponetti, 2022, EJHaem.

Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant

Shannon R. McCurdy, D. Porter, K. Pratz, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria

Adam Bagg, A. Bagg, T. Olson, 2017, British journal of haematology.

Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group

A. Bagg, D. Arber, Craig R Soderquist, 2018, Modern Pathology.

Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?

D. Babushok, E. Hexner, 2014, Current opinion in hematology.

When does a PNH clone have clin i cal sig nif cance ?

D. Babushok, 2021 .

Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia

A. Bagg, T. Olson, S. Schuster, 2019, PloS one.

Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

R. Greenberg, K. Nathanson, S. Domchek, 2022, Clinical genetics.

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers

B. Abella, P. Gimotty, S. Hensley, 2020, JAMA internal medicine.

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial

B. Abella, P. Gimotty, S. Hensley, 2020 .

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

T. Olson, D. Babushok, M. Bessler, 2015, The New England journal of medicine.

Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia

Shannon R. McCurdy, M. Carroll, D. Porter, 2023, American journal of hematology.

Common polymorphic deletion of glutathione S‐transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta‐analysis of 609 patients

J. Biegel, D. Babushok, N. Perdigones, 2013, American journal of hematology.

VWF sequence variants: innocent until proven guilty.

D. Babushok, A. Cuker, 2012, Blood.

A novel testis ubiquitin-binding protein gene arose by exon shuffling in hominoids.

E. Ostertag, H. Kazazian, N. Okada, 2007, Genome research.

One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant

D. Porter, D. Babushok, S. Luger, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

DNA Damage Response Constrains Cell Growth and Drives Clonal Hematopoiesis in Telomere Biology Disorders

D. Babushok, I. Dokal, A. Walne, 2023, Blood.

Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.

J. Biegel, D. Monos, T. Olson, 2015, Cancer genetics.